Knapp, David J. H. F. http://orcid.org/0000-0002-2161-9959
Michaels, Yale S. http://orcid.org/0000-0002-6857-5922
Jamilly, Max
Ferry, Quentin R. V.
Barbosa, Hector
Milne, Thomas A. http://orcid.org/0000-0002-0413-4271
Fulga, Tudor A.
Article History
Received: 14 August 2018
Accepted: 22 February 2019
First Online: 2 April 2019
Competing interests
: T.A.M. is one of the founding shareholders of Oxstem Oncology (OSO), a subsidiary company of OxStem Ltd. All other authors declare no competing interests.